Evoke Pharma | 3: Initial statement of beneficial ownership of securities-Officer Kowieski Mark
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director Hill Malcolm R
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director GARNER CAM L
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director WIDDER KENNETH J
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director REED VICKIE S
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director Brady Todd C
Evoke Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Laurence W. Lytton(9.99%)
Evoke Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals
Evoke Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(9.7%),Altium Growth Fund, LP EIN:(9.7%), etc.
Evoke Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(9.99%),Orin H(9.99%)
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director WIDDER KENNETH J
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director REED VICKIE S
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director Hill Malcolm R
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director GARNER CAM L
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities-Director Brady Todd C
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities
Evoke Pharma | 4: Statement of changes in beneficial ownership of securities
No Data